Status:

TERMINATED

Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction

Lead Sponsor:

Boston Scientific Corporation

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will look at how pacing your heart may assist your daily activities and how you are feeling.

Detailed Description

RESET is a multicenter trial that will assess the effect of pacing in heart failure patients with a normal ejection fraction (or diastolic heart failure). The purpose of the RESET study is to evaluate...

Eligibility Criteria

Inclusion

  • Patients who are in sinus rhythm
  • Patients who are on stable medical therapy
  • Patients who exhibit signs and symptoms of heart failure, New York Heart Association (NYHA) Class II or III
  • Patients who have experienced a hospitalization for decompensated heart failure; treatment for pulmonary congestion or volume overload; chronic treatment with a loop diuretic; or a brain natriuretic peptide (BNP) \> 125 ng/l.
  • Left ventricular ejection fraction (LVEF) ≥ 50%

Exclusion

  • Patients with persistent atrial fibrillation or atrial flutter
  • Patients who are in complete heart block
  • Patients who have experienced a recent myocardial infarction (MI) or have unstable angina or require cardiac surgery or other procedures
  • Patients who have severe heart valve disease or valve replacement
  • Patients with a contraindication for a pacemaker system
  • Patients who have a neuromuscular, orthopedic or other non-cardiac condition that prevents patient from exercise testing
  • Patients who have infiltrative or hypertrophic cardiomyopathy
  • Patients who have known severe pulmonary disease
  • Patients with uncontrolled diabetes or blood pressure (systolic blood pressure (SBP) \> 160 mmHg or diastolic blood pressure (DBP) \> 95 mmHg)

Key Trial Info

Start Date :

July 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2011

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT00670111

Start Date

July 1 2008

End Date

July 1 2011

Last Update

May 19 2017

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Cardiovascular Associates of Northeast Arkansas

Jonesboro, Arkansas, United States, 72401

2

Cardiovascular Associates

Louisville, Kentucky, United States, 40205

3

Johns Hopkins Medical Institutions

Baltimore, Maryland, United States, 21205

4

Mayo Clinic Foundation

Rochester, Minnesota, United States, 55902